Atocha Romero

Cituota

	Visi	Nuo 2019
Šaltiniai	7651	6388
h-rodyklė	34	32
i10-rodyklė	81	71

1600

800

400

1200

201220132014201520162017201820192020202120222023202441 77 111 158 196 235 377 664 907 1212 1367 1585 623

Viešas pasiekiamumas

Peržiūrėti viską

89 straipsniai

11 straipsnių

pasiekiami

nepasiekiami

Pagal finansavimo įpareigojimus

Bendraautoriai

Mariano ProvencioHospital Universitario Puerta de Hierro. Universidad Autónoma de Madrid.Patvirtintas el. paštas salud.madrid.org
Eduardo Diaz-RubioProfesor Medicina. Universidad Complutense. MadridPatvirtintas el. paštas salud.madrid.org
Alberto Cruz BermúdezInvestigador Postdoctoral, Hospital Puerta de HierroPatvirtintas el. paštas idiphim.org
Manuel DomineAssociate Head Oncology. Fundación Jiménez Díaz. IIS - FJD. Head Thoracic Oncology & Clinical TrialsPatvirtintas el. paštas fjd.es
Pedro Pérez SeguraProfesor de medicina, Universidad Complutense de MadridPatvirtintas el. paštas salud.madrid.org
Carlos CampsProfessor MedicinePatvirtintas el. paštas gva.es
Ernest NadalConsultant Medical Oncologist, Thoracic Cancer Unit, Catalan Institute of Oncology, L'HospitaletPatvirtintas el. paštas iconcologia.net
Joaquim Bosch-Barrera (ORCID:0000-...Catalan Institute of Oncology (ICO). University of Girona (UdG). IDIBGI-CERCAPatvirtintas el. paštas iconcologia.net
María José CoronadoInvestigacionPatvirtintas el. paštas idiphim.org
Francisco García-GarcíaResearcher at the Prince Felipe Research Centre (CIPF)Patvirtintas el. paštas cipf.es
Maggie CheangTHE INSTITUTE OF CANCER RESEARCHPatvirtintas el. paštas icr.ac.uk
Noemi ReguartHospital Clinic BarcelonaPatvirtintas el. paštas clinic.ub.es
Gorka Ruiz de GaribayGorka Ruiz de GaribayPatvirtintas el. paštas uib.no
Charles M. PerouUniversity of North Carolina at Chapel HillPatvirtintas el. paštas med.unc.edu
Ana RoyuelaBiostatistics Unit; Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA. CIBERESP, ISCIII.Patvirtintas el. paštas idiphim.org
Julio C. de la Torre-MonteroComillas Pontifical UniversityPatvirtintas el. paštas comillas.edu
Delvys Rodríguez-AbreuMedical Oncologist at Hospital Universitario Insular de Gran Canaria/ Profesor asociado ULPGCPatvirtintas el. paštas gobiernodecanarias.org
Eloisa Jantus-LewintreUniversidad Politécnica de ValenciaPatvirtintas el. paštas gva.es
Mar Vales-GomezPatvirtintas el. paštas cnb.csic.es

Stebėti

Atocha Romero

Hospital Universitario Puerta de Hierro

Patvirtintas el. paštas idiphim.org - Pagrindinis puslapis

cancer lung cancer breast cancer liquid biopsy


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017	1314	2017
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019	901	2019
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial M Provencio, E Nadal, A Insa, MR García-Campelo, J Casal-Rubio, ... The Lancet Oncology 21 (11), 1413-1422, 2020	604	2020
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015	547	2015
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017	354	2017
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013	328	2013
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses H Zhang, TU Ahearn, J Lecarpentier, D Barnes, J Beesley, G Qi, X Jiang, ... Nature genetics 52 (6), 572-581, 2020	305	2020
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer L Wu, W Shi, J Long, X Guo, K Michailidou, J Beesley, MK Bolla, XO Shu, ... Nature genetics 50 (7), 968-978, 2018	213	2018
Overall survival and biomarker analysis of neoadjuvant nivolumab plus chemotherapy in operable stage IIIA non–small-cell lung cancer (NADIM phase II trial) M Provencio, R Serna-Blasco, E Nadal, A Insa, MR García-Campelo, ... Journal of Clinical Oncology 40 (25), 2924-2933, 2022	176	2022
Comparison of methods for circulating cell-free DNA isolation using blood from cancer patients: impact on biomarker testing C Pérez-Barrios, I Nieto-Alcolado, M Torrente, C Jiménez-Sánchez, ... Translational lung cancer research 5 (6), 665, 2016	158	2016
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020	149	2020
Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition A Cruz-Bermúdez, R Laza-Briviesca, RJ Vicente-Blanco, ... Free Radical Biology and Medicine 135, 167-181, 2019	122	2019
Perioperative nivolumab and chemotherapy in stage III non–small-cell lung cancer M Provencio, E Nadal, JL González-Larriba, A Martínez-Martí, R Bernabé, ... New England Journal of Medicine 389 (6), 504-513, 2023	116	2023
Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring D Pérez-Callejo, A Romero, M Provencio, M Torrente Translational lung cancer research 5 (5), 455, 2016	115	2016
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium M Colombo, MJ Blok, P Whiley, M Santamarina, S Gutierrez-Enriquez, ... Human molecular genetics 23 (14), 3666-3680, 2014	103	2014
Assessment of topoisomerase II α status in breast cancer by quantitative PCR, gene expression microarrays, immunohistochemistry, and fluorescence in situ hybridization A Romero, M Martín, MCU Cheang, JAL García-Asenjo, B Oliva, X He, ... The American journal of pathology 178 (4), 1453-1460, 2011	99	2011
Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling A Cruz-Bermúdez, R Laza-Briviesca, RJ Vicente-Blanco, ... Free Radical Biology and Medicine 130, 163-173, 2019	97	2019
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer M Martin, A Romero, MCU Cheang, JA López García-Asenjo, ... Breast cancer research and treatment 128, 127-136, 2011	96	2011
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients A Romero, JA García-Sáenz, M Fuentes-Ferrer, JAL Garcia-Asenjo, ... Annals of oncology 24 (3), 655-661, 2013	77	2013
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging JA García-Saenz, P Ayllón, M Laig, D Acosta-Eyzaguirre, ... BMC cancer 17, 1-8, 2017	76	2017

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai